Physician profile
Christopher Canario
NPI 1467015545
$9,790.92
in general payments reported to CMS, 2019-2025
14 companies · $3,653 in 2025
The $3,653 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2021: $15.57 · 2022: $3,733 · 2023: $63.90 · 2024: $2,066 · 2025: $3,653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,693 · Food and Beverage: $2,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,692.86 |
| Food and Beverage | $2,089.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $3,849.89 | 2022-2024 | |
| Stryker Corporation | $1,871.05 | 2019-2025 | Mako, Inspace, Aequalis Perform Reversed |
| Arthrex, INC. | $1,385.56 | 2025 | |
| Gemini Mountain Medical, LLC | $793.30 | 2024 | |
| Alliance Medical | $696.52 | 2025 | |
| Left Coast Surgical INC | $286.45 | 2025 | |
| Impactortho, INC. | $176.16 | 2024 | |
| Zimmer Biomet Holdings, INC. | $175.97 | 2019-2024 | A.L.P.S. |
| Acumed LLC | $167.69 | 2019-2025 | Acumed |
| Acera Surgical, INC. | $112.05 | 2024 | Restrata Wound Matrix |
| Solventum Corporation | $91.43 | 2024 | V.A.C. Veraflo, Prevena |
| Medtronic, INC. | $83.59 | 2021-2023 | Catalyft Pl Expandable Interbody System |
| Kci USA, INC. | $71.94 | 2019 | |
| Bioventus LLC | $29.32 | 2023 | Exogen Ultrasound Bone Healing System, Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Canario listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.